Evidence map›Paper›PMID 34816982›Full record

ArticleRevista de saude publica2021

Potentially inappropriate prescribing in older adults in Mexico.

Pedro Jesús Saturno-Hernández, Ofelia Poblano-Verástegui, Omar Acosta-Ruiz, Arturo Cuauhtémoc Bautista-Morales, Patricia María Gómez-Cortez, José Luis Alcántara-Zamora, Luis Miguel Gutiérrez-Robledo

Open access · goldAbstract read
In one paragraph

Article in Revista de saude publica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Pedro Jesús Saturno-HernándezCentro de Investigación en Evaluación y Encuestas. Instituto Nacional de Salud Pública. Morelos, México.ORCID http://orcid.org/0000-0002-4991-5805
Ofelia Poblano-VerásteguiCentro de Investigación en Evaluación y Encuestas. Instituto Nacional de Salud Pública. Morelos, México.ORCID http://orcid.org/0000-0001-8879-5861
Omar Acosta-RuizCentro de Investigación en Evaluación y Encuestas. Instituto Nacional de Salud Pública. Morelos, México.ORCID http://orcid.org/0000-0002-9264-2064
Arturo Cuauhtémoc Bautista-MoralesCentro de Investigación en Evaluación y Encuestas. Instituto Nacional de Salud Pública. Morelos, México.ORCID http://orcid.org/0000-0002-8245-8511
Patricia María Gómez-CortezConsorcio Mexicano de Hospitales Privados. Ciudad de México, México.ORCID http://orcid.org/0000-0001-5244-6029
José Luis Alcántara-ZamoraInvestigador independiente. Ciudad de México, México.ORCID http://orcid.org/0000-0003-2660-6935
Luis Miguel Gutiérrez-RobledoInstituto Nacional de Geriatría. Ciudad de México, México.ORCID http://orcid.org/0000-0002-9728-6644
Instituto Nacional de Salud Pública · MXSecretaria de Salud · HNUniversidad Independiente · CR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify and quantify potentially inappropriate prescribing (prescripción potencialmente inapropiada, PPI) and other drug prescribing problems in public health care services in a population-based study at the three existing levels of complexity in Mexico.

methodsDescriptive analysis of the Study on Satisfaction of Users of the Social Protection System in Health 2014-2016, prescription and drug supply section, to obtain the prevalence of PPI in older adults (≥ 65 years), based on Beers, STOPP, Prescrire and BSP listings using AM (older adults) prescription indicators, one for each listing.

resultsMost older adults (67%) were prescribed at least one medication, with a mean of 2.7 medications per prescription. The PPI prevalence was 74% according to the BSP criteria, 67% according to the STOPP listing, 59% with the Beer criteria, and 20% with Prescrire. The most frequent PPI prescriptions were NSAIDs, vasodilators and sulfonylureas.

conclusionsThe use of PPIs in AM is high in Mexico. The higher prevalence found in this study may reflect the use of a source with population representativeness. The partial use and adaptations of the criteria make difficult comparing the studies; however, the STOPP criteria are the ones with the highest prevalence, as they cover a greater number of drugs and their use is more common in the first level of care.

Indexed as

Inappropriate PrescribingPotentially Inappropriate Medication ListAgedBrazilDrug PrescriptionsHumansMexico

Identifiers

PMID34816982
PMCPMC8601402
OpenAlexW3214026609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.